Physician profile
Seri Kwon
NPI 1922501568
$4,782.04
in general payments reported to CMS, 2019-2025
51 companies · $1,210 in 2025
The $1,210 reported for 2025 was more than what 89% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $121 · 2021: $331 · 2022: $1,002 · 2023: $985 · 2024: $1,133 · 2025: $1,210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,298 · Education: $29.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,297.96 |
| Education | $29.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $966.80 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $483.80 | 2019-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Lilly USA, LLC | $473.36 | 2021-2025 | Zepbound, Mounjaro, Jardiance |
| Amgen INC. | $183.51 | 2021-2025 | Repatha, Otezla, Otezla |
| Abbvie INC. | $182.06 | 2022-2025 | |
| Janssen Biotech, INC. | $180.61 | 2022-2025 | Tremfya, Stelara, Simponi Aria |
| Otsuka America Pharmaceutical, INC. | $175.44 | 2021-2025 | Rexulti, Abilify Maintena |
| Madrigal Pharmaceuticals | $171.09 | 2025 | Rezdiffra |
| Boston Scientific Corporation | $144.43 | 2022 | |
| Janssen Scientific Affairs, LLC | $120.37 | 2022 | |
| Medtronic, INC. | $116.07 | 2022-2023 | Minimed 780g |
| Ucb, INC. | $113.33 | 2023-2025 | Cimzia, Bimzelx |
| Takeda Pharmaceuticals U.S.A., INC. | $96.55 | 2021-2025 | Entyvio, Trintellix |
| Lundbeck LLC | $89.28 | 2023-2025 | Rexulti |
| Corcept Therapeutics | $79.34 | 2024-2025 | Korlym |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seri Kwon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.